Published online October 31, 2008
PEDIATRICS Vol. 122 Supplement November 2008, pp. S140-S153 (doi:10.1542/peds.2008-1055g)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zempsky, W. T.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Zempsky, W. T.
Related Collections
Right arrow Office Practice
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

SUPPLEMENT ARTICLE


Pharmacologic Approaches for Reducing Venous Access Pain in Children

William T. Zempsky, MD

Department of Pediatrics, University of Connecticut School of Medicine, Farmington, Connecticut; Pain Relief Program, Connecticut Children's Medical Center, Hartford, Connecticut

A variety of pharmacologic options are available to clinicians who want to provide effective and safe topical local anesthesia to children undergoing venous access procedures. These options can be distinguished on the basis of how they deliver active drug through the impermeable outer layer of skin, the stratum corneum, to pain receptors located in the dermis and epidermis. Three general methodologies are typically used to bypass the stratum corneum: direct injection of local anesthetics, usually via a small-gauge hypodermic syringe; passive diffusion from topical creams or gels; and active needle-free drug strategies that enhance the rate of drug passage into the dermis and epidermis. Examples of the latter mechanisms include heat-enhanced diffusion, iontophoresis, sonophoresis, laser-assisted transdermal passage, and pressurized gas delivery of powdered drug particles. Pharmacologic options in this setting can also be distinguished on the basis of the time to onset of full anesthetic effect. Several available agents induce significant local anesthesia within 1 to 3 minutes of administration, or faster, allowing easy integration into the skin preparation and subsequent venous access procedure. In combination with nonpharmacologic approaches, these agents can be used to dramatically lessen this significant source of pediatric pain.

Key Words: venipuncture • peripheral cannulation • pain • local anesthetics • analgesics • medical device • lidocaine • transdermal administrations • pediatrics

Abbreviations: VAS—visual analog scale • IV—intravenous • LHM—lidocaine hydrochloride monohydrate

Accepted Jun 4, 2008.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 BMJHome page
A. Moore, S. Straube, and H. McQuay
Minimising pain during intravenous cannulation
BMJ, February 10, 2009; 338(feb10_2): a2993 - a2993.
[Full Text]

Home page
 PediatricsHome page
W. T. Zempsky
Optimizing the Management of Peripheral Venous Access Pain in Children: Evidence, Impact, and Implementation
Pediatrics, November 1, 2008; 122(Supplement_3): S121 - S124.
[Full Text] [PDF]